April 04, 2017
A McKesson Corp. investor on Monday filed a derivative suit in California federal court against the company’s board of directors, claiming the board didn’t push the company to comply with the Controlled Substances Act even after paying a $13.25 million penalty in 2008, leading to another $150 million fine in January.